ArticlePostepy dermatologii i alergologii2025
High-frequency ultrasound in the diagnosis of Hidradenitis suppurativa: experience from the Bulgarian HS Expert Centre.
Article in Postepy dermatologii i alergologii, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hidradenitis suppurativa (HS) is an immune-mediated, autoinflammatory skin disease with different clinical manifestations. Traditional clinical examination may not assess HS true extent, while high-frequency ultrasound can detect subclinical lesions, influencing severity assessments. Aim: To compare the clinical severity of HS with the ultrasonography-based staging, and explore relationships between demographic data, risk factors and clinical phenotypes. Material and methods: An ongoing pilot study included 98 patients of the Bulgarian HS Expert Centre. Informed consent and epidemiological data were collected. Patients were categorized into disease duration groups (short/long) and classified by phenotype. Clinical severity was assessed through Hurley, IHS4, and HS-PGA staging systems and by ultrasound using SOS-HS, US IHS4, and US HS-PGA scales. Results: The study cohort was predominately male (74.5%) with a mean age of 36.69 years, average disease duration of 7.6 years and prevalence of the regular phenotype (53%). Age and disease duration correlated with Hurley stage ( Conclusions: HS is often underestimated due to delayed diagnosis and atypical presentations. Combining clinical and ultrasound assessments can provide more accurate staging. A multidisciplinary approach in expert centres can enhance diagnosis, treatment and monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.